logo

For the Inventor, By the Inventor

Grayslake, IL, United States of America

Karen E Rodriques

USPTO Granted Patents = 10

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 156(Granted Patents)


Location History:

  • Grayslake, IL (US) (1991 - 1992)
  • Libertyville, IL (US) (1992)
  • Stowe, MA (US) (1993 - 1994)
  • Stow, MA (US) (1994 - 1995)

Company Filing History:

goldMedal10 out of 4,179 
 
Abbott Laboratories Corporation
 patents

Years Active: 1991-1995

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5459150 - Indole derivatives which inhibit leukotriene biosynthesis (1995-10-17),
2. 5326787 - Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity (1994-07-05),
3. 5288743 - Indole carboxylate derivatives which inhibit leukotriene biosynthesis (1994-02-22),
4. 5187192 - Cyclobutyl derivatives having lipoxygenase inhibitory activity (1993-02-16),
5. 5175183 - Lipoxygenase inhibiting compounds (1992-12-29),
6. 5120752 - Cyclopropyl derivative lipoxygenase inhibitors (1992-06-09),
7. 5095031 - Indole derivatives which inhibit leukotriene biosynthesis (1992-03-10),
8. 5068251 - Lipoxygenase inhibiting compounds (1991-11-26),
9. 5037853 - Cyclopropyl derivative lipoxygenase inhibitors (1991-08-06),
10. 4992464 - Heteroaryl N-hydroxy amides and ureas with polar substituents as (1991-02-12),

Hello! I am Diya, your AI assistant from idiyas.com, focusing on innovations, inventions, inventors, patent attorneys, assignees, and patents. Let's delve into the fascinating world of inventor Karen E Rodriques.

Title:

Innovator Spotlight: Karen E Rodriques - Pioneering Leukotriene Biosynthesis Inhibitors

Introduction:

Karen E Rodriques, a brilliant inventor based in Grayslake, IL, holds an impressive portfolio of 10 patents. Her groundbreaking work primarily revolves around developing compounds that inhibit leukotriene biosynthesis, offering a promising avenue for treating allergic and inflammatory conditions.

Latest Patents:

Karen E Rodriques' recent patents include:

1. Indole derivatives that inhibit leukotriene biosynthesis.

2. Cycloalkyl N-hydroxy derivatives with lipoxygenase inhibitory activity.

3. Compounds with specific structural characteristics that act as potent inhibitors of lipoxygenase enzymes.

Career Highlights:

Currently associated with Abbott Laboratories Corporation, Karen E Rodriques has significantly contributed to the field of pharmaceuticals. Her innovative patents reflect a deep understanding of biochemistry and pharmacology, paving the way for novel therapeutic interventions.

Collaborations:

In her professional journey, Karen E Rodriques has collaborated closely with accomplished colleagues such as Dee W Brooks and Joseph F Dellaria, Jr. Their combined expertise has likely synergized the development of impactful pharmaceutical solutions.

Conclusion:

In conclusion, Karen E Rodriques stands out as a prominent female inventor driving advancements in pharmaceutical research. Her expertise in developing lipoxygenase inhibitors showcases a commitment to improving treatment options for individuals with allergic and inflammatory conditions. We look forward to witnessing further innovations from this talented inventor in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…